EJP PHARMACEUTICAL ApS: Financial statements 2018
CVR: 87923614
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
EJP PHARMACEUTICAL ApS (CVR 87923614) has filed annual accounts for 2018. In 2018, the company reported a net result of DKK -685,356 compared with DKK 1,317,480 the year before. Equity in the 2018 report amounted to DKK 7,127,054. The solvency ratio was 99.2%. The company had 1 employee in the financial year.
- Profit/Loss
- DKK -685,356
- Equity
- DKK 7,127,054
- Total Assets
- DKK 7,182,735
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | - | -685 t. | 7.1 mio. | 1 |
| 2017 | - | -67 t. | 1.3 mio. | 7.9 mio. | 0 |
| 2016 | - | -124 t. | -1.6 mio. | 8.6 mio. | - |
| 2015 | - | -161 t. | 1.6 mio. | 10.2 mio. | - |
| 2014 | - | -221 t. | 642 t. | 8.6 mio. | - |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
EJP PHARMACEUTICAL ApS has published its annual report for 2017. Gross profit came to DKK -67,185, and the net result was DKK 1,317,480.
About EJP PHARMACEUTICAL ApS
EJP PHARMACEUTICAL ApS is a Danish company of the type Anpartsselskab based in Skodsborg, founded in 1982. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Ejvind Jersie Pedersen. The company is owned by Ejvind Jersie Pedersen. The company has 1 employee (2006). In 2025, the company reported a gross profit of DKK -28,266 and a net result of DKK 214,282 compared with DKK 414,071 the year before. Equity in the 2025 report amounted to DKK 814,282.